The PACIFIC, Lung14-179, GEMSTONE-301, and DETERRED studies (17–20) showed that the combination of synchronous or sequential radiotherapy with the anti-PD-1/PD-L1 inhibitors could improve the efficacy of locally advanced NSCLC. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.